» Articles » PMID: 23256751

The Gate That Governs Sulfotransferase Selectivity

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2012 Dec 22
PMID 23256751
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Human cytosolic sulfotransferases (SULTs) transfer the sulfuryl moiety (-SO(3)) from activated sulfate [3'-phosphoadenosine 5'-phosphosulfate (PAPS)] to the hydroxyls and primary amines of numerous metabolites, drugs, and xenobiotics. Receipt of the sulfuryl group often radically alters acceptor-target interactions. How these enzymes select particular substrates from the hundreds of candidates in a complex cytosol remains an important question. Recent work reveals PAPS binding causes SULT2A1 to undergo an isomerization that controls selectivity by constricting the opening through which acceptors must pass to enter the active site. The enzyme maintains an affinity for large substrates by isomerizing between the open and closed states with nucleotide bound. Here, the molecular basis of the nucleotide-induced closure is explored in equilibrium and nonequilibrium molecular dynamics simulations. The simulations predict that the active-site "cap," which covers both the nucleotide and acceptor binding sites, opens and closes in response to nucleotide. The cap subdivides into nucleotide and acceptor halves whose motions, while coupled, exhibit an independence that can explain the isomerization. In silico weakening of electrostatic interactions between the cap and base of the active site causes the acceptor half of the cap to open and close while the nucleotide lid remains shut. Simulations predict that SULT1A1, the most abundant SULT in human liver, will utilize a similar selection mechanism. This prediction is tested using fulvestrant, an anti-estrogen too large to pass through the closed pore, and estradiol, which is not restricted by closure. Equilibrium and pre-steady-state binding studies confirm that SULT1A1 undergoes a nucleotide-induced isomerzation that controls substrate selection.

Citing Articles

Sulfotransferase 4A1 Coding Sequence and Protein Structure Are Highly Conserved in Vertebrates.

van Waardenburg R, Falany C Genes (Basel). 2024; 15(7).

PMID: 39062693 PMC: 11275347. DOI: 10.3390/genes15070914.


A new type of sulfation reaction: -sulfonation for α,β-unsaturated carbonyl groups by a novel sulfotransferase SULT7A1.

Kurogi K, Sakakibara Y, Hashiguchi T, Kakuta Y, Kanekiyo M, Teramoto T PNAS Nexus. 2024; 3(3):pgae097.

PMID: 38487162 PMC: 10939482. DOI: 10.1093/pnasnexus/pgae097.


Role of Conformational Dynamics of Sulfotransferases SULT1A1 and SULT1A3 in Substrate Specificity.

Toth D, Dudas B, Miteva M, Balog E Int J Mol Sci. 2023; 24(23).

PMID: 38069221 PMC: 10706399. DOI: 10.3390/ijms242316900.


Evaluation of the Toxicity Potential of the Metabolites of Di-Isononyl Phthalate and of Their Interactions with Members of Family 1 of Sulfotransferases-A Computational Study.

Ceauranu S, Ciorsac A, Ostafe V, Isvoran A Molecules. 2023; 28(18).

PMID: 37764524 PMC: 10536557. DOI: 10.3390/molecules28186748.


Sulfotransferase 2B1b, Sterol Sulfonation, and Disease.

Cook I, Leyh T Pharmacol Rev. 2022; 75(3):521-531.

PMID: 36549865 PMC: 10158503. DOI: 10.1124/pharmrev.122.000679.


References
1.
Pedersen L, Petrotchenko E, Negishi M . Crystal structure of SULT2A3, human hydroxysteroid sulfotransferase. FEBS Lett. 2000; 475(1):61-4. DOI: 10.1016/s0014-5793(00)01479-4. View

2.
Her C, Kaur G, Athwal R, Weinshilboum R . Human sulfotransferase SULT1C1: cDNA cloning, tissue-specific expression, and chromosomal localization. Genomics. 1997; 41(3):467-70. DOI: 10.1006/geno.1997.4683. View

3.
Whittemore R, Pearce L, Roth J . Purification and kinetic characterization of a phenol-sulfating form of phenol sulfotransferase from human brain. Arch Biochem Biophys. 1986; 249(2):464-71. DOI: 10.1016/0003-9861(86)90023-8. View

4.
Cook I, Wang T, Falany C, Leyh T . A nucleotide-gated molecular pore selects sulfotransferase substrates. Biochemistry. 2012; 51(28):5674-83. PMC: 3448010. DOI: 10.1021/bi300631g. View

5.
Nowell S, Falany C . Pharmacogenetics of human cytosolic sulfotransferases. Oncogene. 2006; 25(11):1673-8. DOI: 10.1038/sj.onc.1209376. View